TTMS on the Silver Level in the Salesforce program
Salesforce certification took place recently and we promised to disclose the results of our specialists. TTMS employees have studied diligently to update their knowledge of operating this powerful CRM platform. Thanks to the regular improvement of competences, we have officially become a Silver Partner.
ReadSlack in the hands of Salesforce
Salesforce is arming itself. It has just agreed on the largest transaction in history – from February 2021, the purchase of Slack, the communicator for collective work, will become a reality. So far, the record of Marc Benioff, CEO of SF, has been the acquisition of Tableau data analysis platform for $ 15 billion. This time […]
ReadAEM Academy – in the search of new Messi
They write in Java. They want to acquire new knowledge. They dream about access to Adobe certificates and educational materials of the highest quality. They are looking for a team of mentors who, within a few months, will prepare them to participate in commercial, large projects and … let them onto the pitch from the […]
ReadSalesforce – TTMS specialists improve their qualifications
The Salesforce Certification Days are approaching – this is the time, when a group of specialists from Transition Technologies MS S.A. sit down to learn to update their knowledge in the field of leading CRM service. Soon many of them will be able to boast of new certificates confirming their skills. And there are 53 […]
ReadSalesforce and Teams integration – cooperation or competition?
#Teams and #salesforce tags in one post? It is fully justified, because from today Salesforce functions as an application, integrated with the Microsoft Teams platform, although both parties still cautiously call it “pilot”. It’s hard to talk about a surprise here, because previously the CRM software vendor chose Microsoft Azure as the cloud provider.
Read
Salesforce creates a vaccine distribution management platform
Currently, about 70 teams are working on a COVID-19 vaccine. These include pharmaceutical concerns, smaller biotechnology companies, academia and non-profit organizations. As impressive as the race is, it’s worth looking at what’s happening in its shadow: the challenge of developing a distribution model. And the venture is unprecedented, as it will involve millions of patients […]
Read